Editorial acerca de “Fístula pancreática posduodenopancreatectomía. Pancreatogastrostomía vs. pancreatoyeyunostomía”

Pancreatic fistula is the most dreaded complication after pancreaticoduodenectomy due to its morbidity and mortality. Multiple procedures to reduce the incidence of this complication have been described: a- Systematic inhibition of pancreatic enzyme secretion using octapeptide in the postoperative period; bUse of biological fibrin-based adhesive to cover and reinforce the anastomosis; c- Use of omentum flap to wrap the pancreatic anastomosis with the jejunum; dAnastomosis with Wirsung duct stenting; e- Telescopic anastomosis; f- Duct-to-mucosa anastomosis (the most commonly used technique today); g- Use of magnification, etc

Download Full-text

Efficacy of octreotide (Octrade) for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography

Medical alphabet ◽

10.33667/2078-5631-2020-30-30-36 ◽

2020 ◽

Vol 1 (30) ◽

pp. 30-36

Author(s):

E. A. Krylova ◽

D. V. Aleinik

Keyword(s):

Endoscopic Retrograde Cholangiopancreatography ◽

Intravenous Infusion ◽

Pancreatic Enzyme ◽

Enzyme Secretion ◽

Continuous Intravenous Infusion ◽

Endoscopic Retrograde ◽

Pancreatic Enzyme Secretion

The article presents the results of a study of the effectiveness of the use of an inhibitor of pancreatic enzyme secretion of octreotide (Octrade) for the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). It was shown that the administration of Octrade at a dose of 0.3 mg in 500 ml of 0.9 % NaCl by continuous intravenous infusion for 7 hours and then 0.1 mg of Octrade subcutaneously at 6 and 12 hours after the end of intravenous infusion significantly reduced the frequency of pancreatitis (4.0 % and 22.2 %; p < 0.05) and hyperamylasemia (8.0 % and 25.9 %; p < 0.05) after ERCP. It is concluded that Octrade is effective in preventing the development of pancreatitis and hyperamilasemia after ERCP.

Download Full-text

MELATONIN METABOLITE; N1-ACETYL-N2-FORMYL-5-METHOXYKYNURAMINE STIMULATES PANCREATIC ENZYME SECRETION VIA CCK RELEASE. STUDY ON THE RATS.

10.26226/morressier.59a6b342d462b80290b53f8f ◽

2017 ◽

Author(s):

Jolanta Maria Jaworek

Keyword(s):

Pancreatic Enzyme ◽

Enzyme Secretion ◽

Pancreatic Enzyme Secretion ◽

Release Study ◽

Cck Release

Download Full-text

Mechanism of galanin's inhibitory action on pancreatic enzyme secretion: modulation of cholinergic transmission--studies in vivo and in vitro.

Gut ◽

10.1136/gut.34.11.1616 ◽

1993 ◽

Vol 34 (11) ◽

pp. 1616-1621 ◽

Cited By ~ 17

Author(s):

K H Herzig ◽

G Brunke ◽

I Schon ◽

M Schaffer ◽

U R Folsch

Keyword(s):

Inhibitory Action ◽

Pancreatic Enzyme ◽

Enzyme Secretion ◽

Cholinergic Transmission ◽

Pancreatic Enzyme Secretion ◽

Transmission Studies

Download Full-text

Pancreatic polypeptide inhibits pancreatic enzyme secretion via a cholinergic pathway

AJP Gastrointestinal and Liver Physiology ◽

10.1152/ajpgi.1987.253.5.g706 ◽

1987 ◽

Vol 253 (5) ◽

pp. G706-G710 ◽

Cited By ~ 3

Author(s):

G. Jung ◽

D. S. Louie ◽

C. Owyang

Keyword(s):

Pancreatic Polypeptide ◽

Acetylcholine Release ◽

Pancreatic Enzyme ◽

Enzyme Secretion ◽

Dependent Manner ◽

Amylase Release ◽

Opioid Receptor Antagonists ◽

Cholinergic Pathway ◽

Pancreatic Enzyme Secretion ◽

Dose Dependent

In rat pancreatic slices, rat pancreatic polypeptide (PP) or C-terminal hexapeptide of PP [PP-(31-36)] inhibited potassium-stimulated amylase release in a dose-dependent manner. The inhibition was unaffected by addition of hexamethonium but blocked by atropine. In contrast, PP(31-36) did not have any effect on acetylcholine- or cholecystokinin octapeptide-stimulated amylase release. In addition, when pancreatic slices were incubated with [3H] choline, PP(31-36) inhibited the potassium-evoked release of synthesized [3H] acetylcholine in a dose-dependent manner. The inhibitory action of PP was unaffected by adrenergic, dopaminergic, or opioid receptor antagonists. Thus PP inhibits pancreatic enzyme secretion via presynaptic modulation of acetylcholine release. This newly identified pathway provides a novel mechanism for hormonal inhibition of pancreatic enzyme secretion via modulation of the classic neurotransmitter function.

Download Full-text